中华耳鼻咽喉头颈外科杂志
中華耳鼻嚥喉頭頸外科雜誌
중화이비인후두경외과잡지
CHINESE JOURNAL OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY
2009年
10期
848-852
,共5页
王馨%谢方云%韩非%胡伟汉%李济时%徐慧敏
王馨%謝方雲%韓非%鬍偉漢%李濟時%徐慧敏
왕형%사방운%한비%호위한%리제시%서혜민
扁桃体肿瘤%放射疗法%预后
扁桃體腫瘤%放射療法%預後
편도체종류%방사요법%예후
Tonsillar neoplasms%Radiotherapy%Prognosis
目的 回顾性分析扁桃体癌的治疗疗效,并探讨影响扁桃体癌的预后因素.方法 1997年4月至2008年4月中山大学肿瘤防治中心共收治经病理证实、无远处转移的扁桃体癌61例,其中末分化癌2例,低分化鳞癌26例,中高分化鳞癌33例.根据AJCC2002年第6版分期标准,Ⅰ期9例,Ⅱ期7例,Ⅲ期23例,Ⅳ期22例.27例患者行单纯放疗,23例行放疗联合化疗,6例行手术联合术后放疗,诱导化疗加手术联合术后放疗3例,放疗后外科挽救加化疗2例.结果 随访率为96.7%.Kaplan-Metier方法 计算全组5年总生存率为50.2%.16例Ⅰ-Ⅱ期患者中,8例行单纯放疗,5年生存率为50.0%,6例行手术联合术后放疗,5年生存率为83.3%,二者差异无统计学意义(P=0.318).45例Ⅲ-Ⅳ期患者,单纯放疗19例,5年生存率为51.5%,放疗联合化疗21例,5年生存率为36.4%,手术联合放疗为主的治疗5例,5年生存率为75.0%,三者差异无统计学意义(P=0.239).T1-T4期5年生存率分别为91.8%、46.8%、29.1%、0%(χ~2=30.168,P<0.001).Cox多因素分析显示T分期、治疗结束时原发灶和颈部转移淋巴结疗效为影响预后的独立危险因素(P<0.05).结论 局部早期(Ⅰ-Ⅱ期)扁桃体癌的治疗,基于器官功能保全原则,倾向于选择单纯放疗,局部晚期(Ⅲ-Ⅳ期)扁桃体癌的治疗模式与疗效的关系仍需进一步研究.T分期、治疗结束时原发灶和颈部转移淋巴结疗效为影响预后的独立危险因素.
目的 迴顧性分析扁桃體癌的治療療效,併探討影響扁桃體癌的預後因素.方法 1997年4月至2008年4月中山大學腫瘤防治中心共收治經病理證實、無遠處轉移的扁桃體癌61例,其中末分化癌2例,低分化鱗癌26例,中高分化鱗癌33例.根據AJCC2002年第6版分期標準,Ⅰ期9例,Ⅱ期7例,Ⅲ期23例,Ⅳ期22例.27例患者行單純放療,23例行放療聯閤化療,6例行手術聯閤術後放療,誘導化療加手術聯閤術後放療3例,放療後外科輓救加化療2例.結果 隨訪率為96.7%.Kaplan-Metier方法 計算全組5年總生存率為50.2%.16例Ⅰ-Ⅱ期患者中,8例行單純放療,5年生存率為50.0%,6例行手術聯閤術後放療,5年生存率為83.3%,二者差異無統計學意義(P=0.318).45例Ⅲ-Ⅳ期患者,單純放療19例,5年生存率為51.5%,放療聯閤化療21例,5年生存率為36.4%,手術聯閤放療為主的治療5例,5年生存率為75.0%,三者差異無統計學意義(P=0.239).T1-T4期5年生存率分彆為91.8%、46.8%、29.1%、0%(χ~2=30.168,P<0.001).Cox多因素分析顯示T分期、治療結束時原髮竈和頸部轉移淋巴結療效為影響預後的獨立危險因素(P<0.05).結論 跼部早期(Ⅰ-Ⅱ期)扁桃體癌的治療,基于器官功能保全原則,傾嚮于選擇單純放療,跼部晚期(Ⅲ-Ⅳ期)扁桃體癌的治療模式與療效的關繫仍需進一步研究.T分期、治療結束時原髮竈和頸部轉移淋巴結療效為影響預後的獨立危險因素.
목적 회고성분석편도체암적치료료효,병탐토영향편도체암적예후인소.방법 1997년4월지2008년4월중산대학종류방치중심공수치경병리증실、무원처전이적편도체암61례,기중말분화암2례,저분화린암26례,중고분화린암33례.근거AJCC2002년제6판분기표준,Ⅰ기9례,Ⅱ기7례,Ⅲ기23례,Ⅳ기22례.27례환자행단순방료,23례행방료연합화료,6례행수술연합술후방료,유도화료가수술연합술후방료3례,방료후외과만구가화료2례.결과 수방솔위96.7%.Kaplan-Metier방법 계산전조5년총생존솔위50.2%.16례Ⅰ-Ⅱ기환자중,8례행단순방료,5년생존솔위50.0%,6례행수술연합술후방료,5년생존솔위83.3%,이자차이무통계학의의(P=0.318).45례Ⅲ-Ⅳ기환자,단순방료19례,5년생존솔위51.5%,방료연합화료21례,5년생존솔위36.4%,수술연합방료위주적치료5례,5년생존솔위75.0%,삼자차이무통계학의의(P=0.239).T1-T4기5년생존솔분별위91.8%、46.8%、29.1%、0%(χ~2=30.168,P<0.001).Cox다인소분석현시T분기、치료결속시원발조화경부전이림파결료효위영향예후적독립위험인소(P<0.05).결론 국부조기(Ⅰ-Ⅱ기)편도체암적치료,기우기관공능보전원칙,경향우선택단순방료,국부만기(Ⅲ-Ⅳ기)편도체암적치료모식여료효적관계잉수진일보연구.T분기、치료결속시원발조화경부전이림파결료효위영향예후적독립위험인소.
Objective To retrospectively analyze the therapeutic effect on patients with tonsillar carcinoma and factors affecting their prognosi. Methods Clinical data of 61 patients pathologically confirmed with tonsillar carcinoma without distant metastasis were analyzed. All the patients were treated in Cancer Center of Sun Yat-sen University from April 1997 to April 2008. There were 2 patients with undifferentiated carcinoma, 26 with poorly differentiated squamous cell carcinoma and 33 with median-well differentiated squamous cell carcinoma. According to the AJCC 2002 staging criteria for head-neck cancers, there were 9 staged Ⅰ cases, 7 staged Ⅱ cases,23 staged Ⅲ cases and 22 staged Ⅳ cases. The treatment was radiotherapy alone in 27 cases, radiotherapy combined with chemotherapy in 23 cases, surgery combined with postoperative radiotherapy in 6 cases, neoadjuvant chemotherapy plus surgery combined with postoperative radiotherapy in 3 cases, radiotherapy with salvage surgery in 2 cases. Results The overall 5-year survival rate was 50. 2%. For 16 cases with staged Ⅰ-Ⅱ staged, there were 8 cases with radiotherapy alone, 5 years survival was 50. 0%, 6 cases with surgery combined with postoperative radiotherapy, 5 years survival was 83.3%. The difference between the two treatments was not significant in statistics (P=0.318). For Ⅲ-Ⅳ staged 45 cases, there were 19 cases with simple radiotherapy, 5 years survival was 51.5%, 21 cases with radiotherapy combined with chemotherapy, 5 years survival was 36.4%, 5 cases with surgery combined with postoperative radiotherapy, 5 years survival was 75.0%. The difference among the three treatments was not significant in statistics (P=0.239). According to T stages, the 5-year survival rates of stage T1-T4 cases were 91.8%, 46.8%, 29.1%, 0% respectively (χ~2=30.168, P<0.001). Multivariate analysis demonstrated that T stage, therapeutic effect of primary site and cervical metastatic lymph node were the independent prognostic factors (P<0.05). Conclusions T stage, the therapeutic effect of primary site and cervical metastatic lymph node were the independent prognostic factors. For Ⅰ-Ⅱ staged tonsillar tumor cases, based on organ preservation, were tendency to choice simple radiotherapy. For Ⅲ-Ⅳ staged cases,yet the ralationships between therapeutic mode and therapeutic effect still need further researches.